Biology and Clinical Application of the Ms Gene
Open Access
- 1 September 2003
- journal article
- other
- Published by SAGE Publications in Tumori Journal
- Vol. 89 (5) , 523-528
Abstract
The sodium iodide symporter (NIS) is a plasma basolateral membrane protein that actively transports iodide to the thyroid follicular cells as the first step of thyroid hormone biosynthesis. NIS also mediates active iodide transport in other human tissues including the salivary glands, lactating mammary gland and gastric mucosa. NIS expression has been recently reported also in several other human tissues but its physiological role is still unclear. Cloning of the NIS gene and the development of specific NIS antibodies have allowed the characterization of the pathogenic role of NIS in thyroid cancer, thyroid autoimmune diseases, congenital hypothyroidism and other, non-thyroidal human diseases. The possibility to increase its levels of expression or to reinduce its expression in thyroid carcinomas that have lost the ability to take up radioiodine is one of the most promising clinically related fields of research. The recent discovery that more than 80% of human breast carcinomas endogenously express NIS protein has opened a very interesting new area of research into the possibility of using radioiodide in the diagnosis and treatment of breast cancer. In an attempt to make tumor cells susceptible to radioiodide destruction, several types of cancer cells have been transfected with the NIS gene. This has demonstrated the feasibility of the in vitro technique but also raised the problem of the absence of the iodide organification machinery in non-thyroidal cells, which, at the moment, represents the major limit of this strategy.Keywords
This publication has 16 references indexed in Scilit:
- Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer TissueBreast Cancer Research and Treatment, 2003
- The sodium iodide symporter: its pathophysiological and therapeutic implicationsClinical Endocrinology, 2002
- Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non–small cell lung cancerCancer Gene Therapy, 2001
- The mammary gland iodide transporter is expressed during lactation and in breast cancerNature Medicine, 2000
- Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidismBiochimie, 1999
- Redifferentiation Therapy with Retinoids: Therapeutic Option for Advanced Follicular and Papillary Thyroid CarcinomaWorld Journal of Surgery, 1998
- Salivary glands1998
- Retinoic Acid Increases Sodium/Iodide Symporter mRNA Levels in Human Thyroid Cancer Cell Lines and Suppresses Expression of Functional Symporter in Nontransformed FRTL-5 Rat Thyroid CellsBiochemical and Biophysical Research Communications, 1997
- Cloning of the Human Sodium Iodide SymporterBiochemical and Biophysical Research Communications, 1996
- Iodide transport in the thyroid glandBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993